Teva reaches $4.25B deal to settle opioid lawsuits | The Hill
Pharmaceutical Company Reaches Settlement With Oklahoma In Opioid Case : NPR
Teva Pharmaceutical (TEVA) bets on market reopening to regain momentum | AlphaStreet
Teva Pays $420 Million to End Generic-Drug Securities Suit (1)
Teva Stock Plunges On Flat Sales, Earnings Disappointment | Investor's Business Daily
Teva Pharmaceuticals - Wikipedia
Teva CEO Richard Francis, after 120 days at the helm, preps grand strategic reveal
teva News and latest stories | The Jerusalem Post
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Teva shares surge after announcing global opioid settlement
Teva Pharmaceutical reports 5% fall in Q4 2022 revenue
Suffering from missteps, drugmaker Teva struggles to heal own ills | The Times of Israel
Teva CEO stands down during troubled times - MedCity News
Teva Announces Launch of $2 Billion (Equivalent) Offering of Sustainability-Linked Senior Notes - ESG News
Teva Pharmaceuticals (@TevaUSA) / Twitter
Teva profit plummets, stock slides | Ctech
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
Teva Pharmaceuticals at heart of major price fixing suit in US - www.israelhayom.com
Teva Pharmaceutical Industries (TEVA) Stock Price, News & Info | The Motley Fool
Teva announces $519 million FCPA settlement | The FCPA Blog
Teva plans massive layoffs; Overland Park office's future unclear - Kansas City Business Journal
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN
Jury finds Teva Pharmaceuticals fueled opioid epidemic in New York State
